Philippe Colombat

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Guillaume Cartron, Laurent Dacheux, Gilles Salles et al. · Blood · 2002 · 1.9K citations · Full text

High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Thierry Philip, Jamés O. Armitage, Gary Spitzer et al. · New England Journal of Medicine · 1987 · 780 citations

Cell Therapy, Refractory Group, Pathology +18

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation

Philippe Colombat · Blood · 2001 · 523 citations

Rituximab-Dependent Cytotoxicity by Natural Killer Cells

Sébastien Dall’Ozzo, Sophie Tartas, Gilles Paintaud et al. · Cancer Research · 2004 · 415 citations

A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

Sophie Camilleri‐Broët, Emmanuelle Crinière, Philippe Broët et al. · Blood · 2005 · 367 citations · Full text